Precipio Q2 Revenue Jumps 24% but Going Concern Doubt Persists
PRPO sits 70% above its 52-week low of $13.8.
Summary
Precipio's Q2 revenue grew 24% to $7.0M, but the company reiterated a going concern warning and disclosed consolidated data security litigation.
Key Events · Earnings and Guidance · PRPO
-
Q2 Revenue Up 24%
Net sales reached $7.0M for Q2 2026, up from $5.7M a year ago, driven by a 26% increase in diagnostic cases processed.
-
Going Concern Warning Reiterated
Management states substantial doubt about the company's ability to continue as a going concern over the next twelve months, citing an accumulated deficit of $104.5M and operating losses.
-
Data Security Litigation Consolidated
Two putative class action lawsuits related to the December 2025 data breach have been consolidated into a single proceeding, with no consolidated complaint filed yet and no liability recorded.
-
New Equipment Loan
In May 2026, the company entered into a $0.3M equipment loan at 8.9% interest, secured by laboratory equipment.
Analysis · PRPO · Industrial Applications And Services
Precipio delivered strong top-line growth with Q2 net sales up 24% to $7.0M, driven by a 26% increase in diagnostic cases. However, the company continues to burn cash with a $2.0M operating loss for the first half of 2026, and management reiterates substantial doubt about its ability to continue as a going concern. The filing also discloses consolidated data security litigation and a new equipment loan, adding legal and financial risk to the growth story.
At the time of this filing, PRPO was trading at $23.50 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $42M. The 52-week trading range was $13.80 to $33.63. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.